Clinical Characteristics and Survival of Patients with Hairy Cell Leukemia Treated at the National Cancer Institute in Peru from 1999 to 2018

被引:0
|
作者
Pena, Estefania [1 ]
Vasquez, Jule [1 ]
机构
[1] Inst Nacl Enfermedades Neoplas, Dept Med Oncol, Lima, Peru
来源
关键词
HCL; hairy cell leukemia; cladribine; rituximab; survival;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IBCL-057
引用
收藏
页码:S399 / S400
页数:2
相关论文
共 50 条
  • [31] SURVIVAL EXPERIENCE OF 195 PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED IN A MULTIINSTITUTIONAL STUDY WITH INTERFERON-ALFA-2B
    GOLOMB, HM
    FEFER, A
    GOLDE, DW
    OZER, H
    PORTLOCK, C
    SILBER, R
    RAPPEPORT, J
    RATAIN, MJ
    THOMPSON, J
    BONNEM, E
    SPIEGEL, R
    TENSEN, L
    BURKE, JS
    VARDIMAN, JW
    LEUKEMIA & LYMPHOMA, 1991, 4 (02) : 99 - 102
  • [32] Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute
    Ornellas, Antonio A.
    Andrade, Dennyson M.
    Ornellas, Paulo
    Wisnescky, Aristoteles
    de Santos Schwindt, Aline B.
    INTERNATIONAL BRAZ J UROL, 2012, 38 (02): : 185 - 194
  • [33] Clinical Characteristics and Survival of Non- Nasal Natural Killer/T-Cell Lymphoma from 2 Cancer Centers from Peru
    Vasquez, Jule F.
    Castro, Melanie
    Diaz, Alonso
    Barrionuevo, Carlos
    Samanez-Figari, Cesar
    BLOOD, 2021, 138
  • [34] INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA - AN UPDATE ON A COHORT OF 69 PATIENTS TREATED FROM 1983 TO 1986
    SPIELBERGER, RT
    MICK, R
    RATAIN, MJ
    GOLOMB, HM
    LEUKEMIA & LYMPHOMA, 1994, 14 : 89 - 93
  • [35] Clinical Outcome and Treatment-Related Mortality in Patients with Acute Myeloid Leukemia Treated at the Uganda Cancer Institute
    Okello, Clement Dove
    Meshinchi, Soheil
    Tarlock, Katherine
    Warren, Edus H.
    Towlerton, Andrea M. H.
    Ddungu, Henry
    Mulumba, Yusuf
    Geriga, Fadhil
    Orem, Jackson
    Balagadde, Joyce K.
    BLOOD, 2022, 140 : 8940 - 8941
  • [36] A VARIANT FORM OF HAIRY-CELL LEUKEMIA RESISTANT TO ALPHA-INTERFERON - CLINICAL AND PHENOTYPIC CHARACTERISTICS OF 17 PATIENTS
    SAINATI, L
    MATUTES, E
    MULLIGAN, S
    DEOLIVEIRA, MP
    RANI, S
    LAMPERT, IA
    CATOVSKY, D
    BLOOD, 1990, 76 (01) : 157 - 162
  • [37] Candida species isolated from urine and vaginal samples from cancer patients treated at the National Institute of Neoplastic Diseases (INEN), Lima, Peru. Fingerprinting of Candida albicans
    Arce-Gil, Zhandra
    Viviana-Silva A
    Victor-Silva
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2015, 8 (03): : 168 - 173
  • [38] Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group
    Viallet, J
    Stewart, D
    Shepherd, F
    Ayoub, J
    Cormier, Y
    Dipietro, N
    Steward, W
    LUNG CANCER, 1996, 15 (03) : 367 - 373
  • [39] HEMODIALYSIS IN CERVICAL CANCER PATIENTS: CLINICAL ASPECTS AND OUTCOME IN 95 PATIENTS FROM THE BRAZILIAN NATIONAL CANCER INSTITUTE (INCA)
    Candido Reis, D. G.
    Soares, L. M. C.
    Herchenhorn, D.
    Martins, I. S.
    Rocha, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 524 - 524
  • [40] INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA - AN UPDATE ON A COHORT OF 69 PATIENTS TREATED FROM 1983-1986
    GOLOMB, HM
    RATAIN, MJ
    MICK, R
    DALY, K
    LEUKEMIA, 1992, 6 (11) : 1177 - 1180